Trial Profile
Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2009
Price :
$35
*
At a glance
- Drugs Plozalizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Millennium
- 20 Sep 2009 New trial record.